Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002494-19Phase 4Terminated
Phase 4, randomised trial of dexamethasone in inflammation (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Feasibility of SPP-RC trial design. Started Jul 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002494-19.